MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 16.03.2026
Assertio Holdings P/S 2011-2026 | ASRT
P/S Jährlich Assertio Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.635 | 0.598 | 0.434 | 1.78 | 0.894 | 0.621 | 0.336 | 0.898 | 1.22 | 2.38 | 2.69 | 2.73 | 5.09 | 4.06 | 2.49 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.09 | 0.336 | 1.79 |
P/S anderer Aktien in der Arzneimittelhersteller
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
18.8 | - | 7.5 % | $ 6.35 M |  USA |
 |
Aerie Pharmaceuticals
AERI
|
1.68 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
0.066 | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3.78 | - | 0.86 % | $ 117 M | USA |
 |
DURECT Corporation
DRRX
|
3.72 | - | - | $ 50.1 M | USA |
 |
Cronos Group
CRON
|
77.6 | $ 2.65 | -1.85 % | $ 1.36 B |  Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
8.49 | $ 4.28 | 2.15 % | $ 60.2 M | USA |
 |
Catalent
CTLT
|
2.48 | - | - | $ 11.5 B | USA |
 |
Alimera Sciences
ALIM
|
1.26 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
0.111 | - | -23.39 % | $ 1.76 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.07 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
0.0339 | - | - | $ 28.9 M |  Irlanda |
 |
Avadel Pharmaceuticals plc
AVDL
|
4.24 | - | - | $ 2.06 B |  France |
 |
Evoke Pharma
EVOK
|
0.432 | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
6.01 K | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
0.719 | - | 2.45 % | $ 38.1 M | Canada |
 |
Bausch Health Companies
BHC
|
0.386 | $ 5.67 | 1.61 % | $ 2.07 B | Canada |
 |
Canopy Growth Corporation
CGC
|
0.528 | $ 1.15 | -4.17 % | $ 124 M | Canada |
 |
Jupiter Wellness
JUPW
|
3.37 | - | - | $ 33.6 M | USA |
 |
Harrow Health
HROW
|
7.1 | $ 40.48 | -2.25 % | $ 1.49 B | USA |
 |
Lannett Company
LCI
|
0.0823 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
4.82 | $ 1.4 | -2.78 % | $ 402 M | Canada |
 |
Evolus
EOLS
|
0.913 | $ 5.27 | 0.96 % | $ 340 M | USA |
 |
Sundial Growers
SNDL
|
0.0158 | $ 1.47 | -2.65 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
0.132 | $ 8.23 | 2.49 % | $ 421 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
2.11 | - | - | $ 193 M | Canada |
 |
Organogenesis Holdings
ORGO
|
0.86 | $ 2.4 | 0.42 % | $ 316 M | USA |
 |
Pacira BioSciences
PCRX
|
5.13 | $ 25.41 | -0.55 % | $ 1.18 B | USA |
 |
Radius Health
RDUS
|
1.64 | - | - | $ 1.42 B | USA |
 |
ProPhase Labs
PRPH
|
1.06 | - | - | $ 5.07 M | USA |
 |
cbdMD
YCBD
|
0.0863 | $ 0.91 | -6.19 % | $ 3.92 M | USA |
 |
PetIQ
PETQ
|
0.36 | - | 1.64 % | $ 400 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
0.256 | $ 1.04 | -6.31 % | $ 1.29 M | USA |
 |
Tilray
TLRY
|
1.9 | $ 6.56 | -4.79 % | $ 4.05 B | Canada |
 |
Recro Pharma
REPH
|
1.41 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
2.7 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
1.84 | $ 0.99 | -1.42 % | $ 49.4 M | USA |
 |
PLx Pharma
PLXP
|
14.4 | - | -27.8 % | $ 2.56 M | USA |
 |
Veru
VERU
|
6.39 | $ 2.29 | -2.14 % | $ 309 M | USA |
 |
Viatris
VTRS
|
1.19 | $ 14.82 | 0.07 % | $ 17.8 B | USA |
 |
Aurora Cannabis
ACB
|
3.73 | $ 3.42 | -2.56 % | $ 86.3 M | Canada |
 |
Zomedica Corp.
ZOM
|
5.45 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
895 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
0.488 | $ 0.89 | 5.24 % | $ 32 M | USA |
 |
China Pharma Holdings
CPHI
|
0.663 | $ 0.56 | -4.13 % | $ 2.4 M |  China |
 |
TherapeuticsMD
TXMD
|
7.62 | $ 2.1 | 1.45 % | $ 24.3 M | USA |